Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence (Q35106116)

6 August 2017

1 reference

title

Inflammation, endothelial dysfunction, and the risk of high blood pressure: epidemiologic and biological evidence (English)

1 reference

6 August 2017

0 references

Bautista LE

1

1 reference

6 August 2017

publication date

1 April 2003

1 reference

Journal of Human Hypertension

6 August 2017

published in

1 reference

6 August 2017

volume

17

1 reference

6 August 2017

issue

4

1 reference

6 August 2017

page(s)

223-230

1 reference

Prevalence of Hypertension in the US Adult Population : Results From the Third National Health and Nutrition Examination Survey, 1988-1991

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Acute systemic inflammation impairs endothelium-dependent dilatation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

C-reactive protein and coronary heart disease in western Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Distribution of serum C-reactive protein and its association with atherosclerotic risk factors in a Japanese population : Jichi Medical School Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Is C-reactive protein an independent risk factor for essential hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Plasma tumor necrosis factor alpha levels and insulin sensitivity in hypertensive subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Association of serum tumour necrosis factor-alpha with serum low-density lipoprotein-cholesterol and blood pressure in apparently healthy Japanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

IL-6 and APPs: anti-inflammatory and immunosuppressive mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Preactivated peripheral blood monocytes in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Shedding of TNF-alpha receptors, blood pressure, and insulin sensitivity in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Colombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV). Normal values and factors associated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Regulatory functions of the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Endothelium-derived hyperpolarizing factor: a new endogenous inhibitor from the vascular endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Vascular endothelial cells synthesize nitric oxide from L-arginine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Endothelium-dependent hyperpolarization: a role in the control of vascular tone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Secondary endothelial dysfunction: hypertension and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

High doses of vitamin C reverse Escherichia coli endotoxin-induced hyporeactivity to acetylcholine in the human forearm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Effects of antihypertensive drugs on endothelial dysfunction: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Prognostic significance of endothelial dysfunction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

High-shear-stress-induced activation of platelets and microparticles enhances expression of cell adhesion molecules in THP-1 and endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Effect of antihypertensive treatment on endothelium-dependent vascular relaxation in patients with essential hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Relation of inflammation to vascular function in patients with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Is C-reactive protein an independent risk factor for essential hypertension?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Low-grade systemic inflammation in overweight children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

Medical care expenditures for hypertension, its complications, and its comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Impaired endothelial function with essential hypertension assessed by ultrasonography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Endothelium-Dependent Forearm Vasodilation Is Reduced in Normotensive Subjects with Familial History of Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Serum C-reactive protein and self-reported stroke: findings from the Third National Health and Nutrition Examination Survey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

C-Reactive Protein in Offspring Is Associated With the Occurrence of Myocardial Infarction in First-Degree Relatives

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

The acute phase response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Blood pressure and inflammation in apparently healthy men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Association of cardiovascular risk factors and endothelial dysfunction in japanese hypertensive patients: implications for early atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac ateries and inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Molecular mechanisms and therapeutic strategies related to nitric oxide.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Defective L-arginine-nitric oxide pathway in offspring of essential hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Hypertension causes premature aging of endothelial function in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001537

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001537

1 reference

6 August 2017

1 reference